Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma
Clinical trial NCT03031483 · COMPLETED
Trial details
- NCT number
- NCT03031483
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-03
- Primary completion
- 2019-11-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.